Dose 3 | List of Frontiers open access articles

Original Research

Published on 13 Nov 2025

Effects of zinc supplementation on milk production performance and growth status of Bactrian camels

in Animal Nutrition and Metabolism

Xinrui Zhou
Menglei Jiang
Muhammad Amjad
Khosbileg
Miaoyu Liu
Zihui Wu
Jiarui Cheng
Jiabin Tang
Linghua Xu
Xuedan Zhu

Frontiers in Veterinary Science

doi 10.3389/fvets.2025.1677915

1,412 views

Original Research

Published on 20 Sep 2022

Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity

in Primary Immunodeficiencies

Daniel Leung
Xiaofeng Mu
Jaime S. Rosa Duque
Samuel M. S. Cheng
Manni Wang
Wenyue Zhang
Yanmei Zhang
Issan Y. S. Tam
Toby S. S. Lee
Jennifer H. Y. Lam

Frontiers in Immunology

doi 10.3389/fimmu.2022.982155

6,176 views
16 citations

Clinical Trial

Published on 05 Jul 2019

A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy

in Gastroenterology

Xu Tian
Bing Shi
Xiao-Ling Liu
Hui Chen
Wei-Qing Chen

Frontiers in Medicine

doi 10.3389/fmed.2019.00158

4,615 views
12 citations

Original Research

Published on 22 May 2023

CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach

in Cancer Immunity and Immunotherapy

Kousain Kousar
Faiza Naseer
Maisa Siddiq Abduh
Sadia Anjum
Tahir Ahmad

Frontiers in Immunology

doi 10.3389/fimmu.2023.1175535

7,068 views
25 citations

Original Research

Published on 23 Oct 2024

Antimutagenic and anticoagulant therapeutic effects of Ag/Ag2O nanoparticles from Olea europaea leaf extract: mitigating metribuzin-induced hepato-and nephrotoxicity

in Experimental Pharmacology and Drug Discovery

Manel Azzi
Ibtissam Laib
Abderrhmane Bouafia
Ifriqya Medila
Ali Tliba
Salah Eddine Laouini
Huda Alsaeedi
David Cornu
Mikhael Bechelany
Ahmed Barhoum

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485525

4,355 views
27 citations

Original Research

Published on 21 Jan 2025

Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections

in Primary Immunodeficiencies

Dana Unninayar
Emilia L. Falcone
Hugo Chapdelaine
Donald C. Vinh
Karina A. Top
Beata Derfalvi
Thomas B. Issekutz
Hélène Decaluwe
Anne Pham-Huy
Julia Upton

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501908

4,038 views
2 citations

Clinical Trial

Published on 16 Oct 2023

Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial

in Vaccines and Molecular Therapeutics

Alphonse Ouédraogo
Edith Christiane Bougouma
Nirianne Marie Q. Palacpac
Sophie Houard
Issa Nebie
Jean Sawadogo
Gloria D. Berges
Issiaka Soulama
Amidou Diarra
Denise Hien

Frontiers in Immunology

doi 10.3389/fimmu.2023.1267372

5,881 views
8 citations

Articles

Effects of zinc supplementation on milk production performance and growth status of Bactrian camels

Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity

A Randomized Trial of Split Dose 3 L Polyethylene Glycol Lavage Solution, 2 L Polyethylene Glycol Lavage Combined With Castor Oil, and 1 L of Polyethylene Glycol Lavage Solution Combined With Castor Oil and Ascorbic Acid for Preparation for Colonoscopy

CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach

Antimutagenic and anticoagulant therapeutic effects of Ag/Ag2O nanoparticles from Olea europaea leaf extract: mitigating metribuzin-induced hepato-and nephrotoxicity

Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infections

Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial